Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: A meta-analysis of randomized controlled trials

European Heart Journal

Volumn 30, Issue 1, 2009, Pages 44-55

  Kasapis, Christos ^a   Henke, Peter K ^b   Chetcuti, Stanley J ^a   Koenig, Gerald C ^a   Rectenwald, John E ^b   Krishnamurthy, Venkataramu N ^b   Grossman, Paul Michael ^a   Gurm, Hitinder S ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Angioplasty; Balloon; Meta analysis; Peripheral vascular disease; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NITINOL; TICLOPIDINE;

ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; FEMOROPOPLITEAL ARTERY DISEASE; FOLLOW UP; HUMAN; META ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; RISK; STENT; SYSTEMATIC REVIEW; TARGET VESSEL REVASCULARIZATION;

AGED; ANGIOPLASTY, BALLOON; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK; STENTS; TREATMENT OUTCOME;

EID: 58149169179     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn514     Document Type: Article

References (29)

1. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110:738- 743.
2. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-1324.
3. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33(Suppl. 1):S1-S75.
4. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans-Atlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:e463-e654.
5. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA 1995;274:165-171.
6. Muradin GS, Bosch JL, Stijnen T, Hunink MG. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 2001;221:137-145.
7. Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, van de Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 1997;20:420-425.
8. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
9. Saxon RR, Coffman JM, Gooding JM, Natuzzi E, Ponec DJ. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 2003;14:303-311.
10. Zdanowski Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thorne J, Norgren L. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol 1999;18:251-255.
11. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-1888.
12. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115:2745-2749.
13. Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg 2003;37:487-494.
14. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, Lammer J. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 2001;12:23-31.
15. US Food and Drug Administration. Center for Devices and Radiological Health. Intracoil self-expanding peripheral stent - P000033 (2001). http://www.fda.gov/cdrh/pdf/p000033.html (November 2007).
16. US Food and Drug Administration, Center for Devices and Radiological Health. Gore Viabahn Endoprosthesis - P040037 (2005). http://www.fda.gov/cdrh/ pdf4/p040037.html (November 2007).
17. Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tubler T, Zeller T. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007;116:285- 292.
18. Grimm J, Muller-Hulsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 2001;12:935-942.
19. Orwin R. A fail-safe N for effect size in meta-analysis. J Educ Stat 1983;8:157-159.
20. Rosenberg MS. The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis. Evol Int J Org Evol 2005;59:464-468.
21. Katzen BT, Laird J; RESILIENT investigators. The RESILIENT trial. 12-month analysis. In: TCT 2007 (Transcatheter Cardiovascular Therapeutics). Washington, DC, 20-25 October 2007. http://www. cardiosource.com/clinicaltrials/trial.asp?trialID51615 (5 November 2008).
22. Cejna M, Schoder M, Lammer J. [PTA vs. stent in femoro-popliteal obstruction]. Radiologe 1999;39:144-150.
23. Grenacher L, Saam T, Geier A, Muller-Hulsbeck S, Cejna M, Kauffmann GW, Richter GM. [PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA)]. Rofo 2004;176:1302-1310.
24. Greenberg D, Rosenfield K, Garcia LA, Berezin RH, Lavelle T, Fogleman S, Cohen DJ. In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial). J Vasc Interv Radiol 2004;15:1065-1069.
25. Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M, Biamino G, Schmidt A. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-315.
26. Hayerizadeh R, Zeller T, Krankenberg H, Scheinert D, Rastan A, Geier S, Braunlich S, Wegscheider K, Biamino G. Long-term outcome of superficial femoral artery stenting using nitinol stents compared with stainless steel stents. A multicenter study. Am J Cardiol 2003;92(suppl):S157.
27. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, Minar E. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 2004;232:516-521.
28. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-1934.
29. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987;107:224-233.